ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 87 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,870,000 | +323.8% | 2,525,654 | +87.0% | 0.12% | +400.0% |
| Q4 2019 | $1,621,000 | -20.5% | 1,350,655 | 0.0% | 0.02% | -41.0% |
| Q3 2019 | $2,039,000 | -62.4% | 1,350,655 | 0.0% | 0.04% | -53.6% |
| Q2 2019 | $5,430,000 | -6.5% | 1,350,655 | 0.0% | 0.08% | -6.7% |
| Q1 2019 | $5,808,000 | -25.2% | 1,350,655 | 0.0% | 0.09% | -37.5% |
| Q4 2018 | $7,766,000 | -14.1% | 1,350,655 | +102.6% | 0.14% | +32.1% |
| Q3 2018 | $9,039,000 | +14.2% | 666,593 | 0.0% | 0.11% | +16.0% |
| Q2 2018 | $7,912,000 | -18.7% | 666,593 | -23.1% | 0.09% | -22.3% |
| Q1 2018 | $9,732,000 | -23.9% | 866,593 | -54.7% | 0.12% | -25.3% |
| Q4 2017 | $12,790,000 | -18.4% | 1,914,660 | 0.0% | 0.16% | +8.0% |
| Q3 2017 | $15,681,000 | +82.4% | 1,914,660 | 0.0% | 0.15% | +66.7% |
| Q2 2017 | $8,597,000 | -18.5% | 1,914,660 | 0.0% | 0.09% | -25.0% |
| Q1 2017 | $10,550,000 | +259.7% | 1,914,660 | +164.4% | 0.12% | +224.3% |
| Q4 2016 | $2,933,000 | -42.5% | 724,184 | 0.0% | 0.04% | -36.2% |
| Q3 2016 | $5,105,000 | -13.5% | 724,184 | 0.0% | 0.06% | -6.5% |
| Q2 2016 | $5,902,000 | +65.5% | 724,184 | +65.0% | 0.06% | +63.2% |
| Q1 2016 | $3,567,000 | -32.6% | 438,784 | 0.0% | 0.04% | -20.8% |
| Q4 2015 | $5,292,000 | +150.6% | 438,784 | +148.6% | 0.05% | +128.6% |
| Q3 2015 | $2,112,000 | -97.4% | 176,470 | -96.0% | 0.02% | -96.5% |
| Q2 2015 | $80,857,000 | – | 4,411,186 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |